Isidre Casals Alsina
Isidre Casals Alsina
Specialist Physician in Pediatrics and its Special Areas
Pediatricsen/specialities/pediatrics
See more specialists on
Barcelonabarcelona
en/medical-staff/pediatrician
Dr. Isidre Casals Alsina is a leading pediatrician specializing in specific areas of pediatrics. He graduated with a degree in Medicine and Surgery in 1992 and subsequently specialized in Pediatrics. He currently practices as a specialist at the Hospital Universitario General de Catalunya, where he has been active since 2002. His most notable publication, "Impact of influenza virus infection in hospitalized patients with fever," was published in the journal Acta Pediátrica Española in 2012. Dr. Casals is also a member of the Vaccine Working Group of the Sociedad Catalana de Pediatría, reflecting his commitment to research and advancement in the field of pediatrics. His professional career is marked by a constant dedication to improving children's health, establishing him as a respected figure in his specialty.
Key information
- Latest Publication:Impact of influenza virus infection in hospitalized patients with fever
- Belongs to:Grupo de Trabajo de Vacunas
Professional Details
Hospital Universitari General de Catalunya
SPECIALIST PHYSICIAN PAEDIATRICS AND RELATED AREAS
November 2002
Centre Mèdic Quirónsalud Rubí
SPECIALIST PHYSICIAN PAEDIATRICS AND RELATED AREAS
November 2002
Hospital Gral. de Vic
Attending Pediatrician
January 1997
Hospital Gral. de Vic
Specialist doctor
January 1997
Study
Bachelor of Medicine and Surgery
1992
Specialized Healthcare Training
Specialist in Pediatrics and its specific areas
Evaluation of the impact of probiotic type, delivery method, and breastfeeding method on newborns after dysbiotic delivery
2022
sars-cov-2 rna vaccine candidate against covid-19
2021
A phase 1, open-label dose-finding study to evaluate safety, tolerability, and immunogenicity and phase 2/3 placebo controlled, observer-blinded safety, tolerability, and immunogenicity study of a sars-cov-2 rna vaccine candidate against covid-19 in healthy children and young adults
2021
A phase 3, randomized, double-blind trial to evaluate the safety of a 20-valent pneumococcal conjugate vaccine
2020
A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897
2019
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897
2019
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants
2019
A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children
2019
Extension study of V72_28
2014
Open-label, multicenter, phase IIIB extension study of V72_28 to evaluate antibody persistence and the safety and tolerability of a booster dose after completion of the V72_28 study vaccination program
2014
HERMES Studio
2011
Prospective epidemiological study of pediatric patients with middle ear exudate belonging to a well-defined health area in Terrassa, Barcelona (HERMES Study)
2011
Evaluation of the impact of probiotic type, delivery type, and breastfeeding type on the evolution of the gut microbiota in newborns following dysbiotic delivery
2022
Impact of influenza virus infection in hospitalized patients with fever
Malignant pertussis in an unvaccinated infant
Grupo de Trabajo de Vacunas
Make an appointment with this professional
Vídeos de
Consulta el contenido multimedia de este profesional.
Hospitals
Book an appointment now at one of our hospitals.
Hospital Universitari General de Catalunya
Pedro i Pons, 1
08190 Sant Cugat del Vallés Barcelona
Centre Mèdic Quirónsalud Rubí
Paseo Pau Clarís / Calle Cadmo
08191 Rubí Barcelona
Articles on
Browse the latest articles on Tu canal de salud.
¿No tienes seguro de salud?
Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.